In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.

In Episode 4, the final segment, Jones offered his insights for when he considers discharging patients.

In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.

In Episode 3, Jones covers concerns around empirical antimicrobial treatment and opportunities to narrow down therapies.

In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.

In Episode 2, Jones offers clinical considerations for patient dosing and clinical management strategies associated with concurrent therapy.

In this Contagion News Network series, Clinical Care for Hospitalized ABSSSI Patients with Comorbidities, we're joined by Bruce Jones, PharmD, FIDSA, BCPS, who offers his commentary and thoughts on the clinical management of patients with acute bacterial skin and skin structure infections.

In Episode 1, Jones discusses treating challenging patients with comorbidities such as type 2 diabetes, higher BMI, and advanced age.

Christian Sandrock, MD, MPH, FCCP, highlights key takeaways on approaching treatment of antimicrobial resistant gram-negative infections as presented in updated IDSA guidelines and ID week 2023.

George Sakoulas, MD, provides key insights on the management of soft tissue infections including the role of single-dose agents and treating patients in an outpatient setting.

An expert in infectious diseases shares treatment considerations and clinical strategies for the management of community acquired pneumonia (CAP).

COVID-19 reshaped the landscape of urinary tract infections (UTIs). Explore the prevalence of resistant pathogens, the impact on infection prevention, and the changes in positive pathogens.